Ncf1 provides a reactive oxygen species-independent negative feedback regulation of TLR9-induced IL-12p70 in murine dendritic cells

Journal of Immunology

Volumn 182, Issue 7, 2009, Pages 4183-4191

  Richter, Cornelia ^a   San Juan, Martina Herrero ^a   Will, Jutta ^a   Brandes, Ralf P ^a   Kalinke, Ulrich ^b   Akira, Shizuo ^c   Pfeilschifter, Josef M ^a   Hultqvist, Malin ^d   Holmdahl, Rikard ^d   Radeke, Heinfried H ^a  

^a GOETHE UNIVERSITY   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

^c OSAKA UNIVERSITY   (Japan)

^d LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CPG OLIGODEOXYNUCLEOTIDE; DIPHENYLIODONIUM SALT; GAMMA INTERFERON; GENE PRODUCT; INTERLEUKIN 10; INTERLEUKIN 12P70; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; OVALBUMIN; PROTEIN NCF1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG; INTERLEUKIN 12; MYD88 PROTEIN, MOUSE; NEUTROPHIL CYTOSOLIC FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ELECTRON TRANSPORT; EXON; FEEDBACK SYSTEM; GENE; GENE FUNCTION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NCF1 GENE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL; TH1 CELL; ANIMAL; C57BL MOUSE; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; DENDRITIC CELLS; FEEDBACK, BIOCHEMICAL; FLOW CYTOMETRY; INTERLEUKIN-12; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9;

EID: 64249162497     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0800795     Document Type: Article

References (52)

1. Olofsson, P., J. Holmberg, J. Tordsson, S. Lu, B. Akerstrom, and R. Holmdahl. 2003. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat. Genet. 33: 25-32. (Pubitemid 36068678)
2. Gelderman, K. A., M. Hultqvist, L. M. Olsson, K. Bauer, A. Pizzolla, P. Olofsson, and R. Holmdahl. 2007. Rheumatoid arthritis: the role of reactive oxygen species in disease development and therapeutic strategies. Antioxid. Redox Signal. 9: 1541-1567.
3. Hultqvist, M., P. Olofsson, J. Holmberg, B. T. Backstrom, J. Tordsson, and R. Holmdahl. 2004. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc. Natl. Acad. Sci. USA 101: 12646-12651. (Pubitemid 39122077)
4. phox mouse knockout model of chronic granulomatous disease. J. Exp. Med. 182: 751-758.
5. phox-/- mouse model of chronic granulomatous disease has normal granuloma formation and cytokine responses to Mycobacterium avium and Schistosoma mansoni eggs. Infect. Immun. 67: 1659-1665.
6. Babior, B. M. 2004. NADPH oxidase. Curr. Opin. Immunol. 16: 42-47.
7. Cross, A. R., and A. W. Segal. 2004. The NADPH oxidase of professional phagocytes-prototype of the NOX electron transport chain systems. Biochim. Biophys. Acta 1657: 1-22.
8. Sheppard, F. R., M. R. Kelher, E. E. Moore, N. J. McLaughlin, A. Banerjee, and C. C. Silliman. 2005. Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation. J. Leukocyte Biol. 78: 1025-1042. (Pubitemid 41572466)
9. phox homology domain from SH3 domain toward phosphoinositides, leading to phagocyte NADPH oxidase activation. Proc. Natl. Acad. Sci. USA 100: 4474-4479.
10. phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites. J. Clin. Invest. 116: 2033-2043.
11. phox, a cytosolic subunit of the leukocyte NADPH oxidase: phosphorylation of Ser-359 or Ser-370 precedes phosphorylation at other sites and is required for activity. J. Biol. Chem. 273: 35147-35152.
12. Trinchieri, G., and A. Sher. 2007. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 7: 179-190. (Pubitemid 46310482)
13. Uematsu, S., and S. Akira. 2007. Toll-like receptors and type I interferons. J. Biol. Chem. 282: 15319-15323.
14. Pacquelet, S., J. L. Johnson, B. A. Ellis, A. A. Brzezinska, W. S. Lane, D. B. Munafo, and S. D. Catz. 2007. Cross-talk between IRAK-4 and the NADPH oxidase. Biochem. J. 403: 451-461.
15. Kim, T. W., K. Staschke, K. Bulek, J. Yao, K. Peters, K.-H. Oh, Y. Vandenburg, H. Xiao, W. Qian, T. Hamilton, et al. 2007. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J. Exp. Med. 204: 1025-1036.
16. Takeshita, F., K. J. Ishii, K. Kobiyama, Y. Kojima, C. Coban, S. Sasaki, N. Ishii, D. M. Klinman, K. Okuda, S. Akira, and K. Suzuki. 2005. TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF. Eur. J. Immunol. 35: 2477-2485. (Pubitemid 41179769)
17. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146. (Pubitemid 37328691)
18. Babik, J. M., E. Adams, Y. Tone, P. J. Fairchild, M. Tone, and H. Waldmann. 1999. Expression of murine IL-12 is regulated by translational control of the p35 subunit. J. Immunol. 162: 4069-4078.
19. Kang, B. Y., and T. S. Kim. 2006. Targeting cytokines of the interleukin-12 family in autoimmunity. Curr. Med. Chem. 13: 1149-1156.
20. Dai, J., B. Liu, D. J. Cua, and Z. Li. 2007. Essential roles of IL-12 and dendritic cells but not IL-23 and macrophages in lupus-like diseases initiated by cell surface HSP gp96. Eur. J. Immunol. 37: 706-715.
21. Murphy, C. A., C. L. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, R. A. Kastelein, J. D. Sedgwick, and D. J. Cua. 2003. Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198: 1951-1957.
22. phox-deficient mice. J. Biol. Chem. 277: 5468-5475.
23. phox phosphorylation and binding to TRAF4. Mol. Cell. Biol. 25: 2320-2330.
24. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143-150. (Pubitemid 28361303)
25. Hoebe, K., Z. Jiang, P. Georgel, K. Tabeta, E. Janssen, X. Du, and B. Beutler. 2006. TLR signaling pathways: opportunities for activation and blockade in pursuit of therapy. Curr. Pharm. Des. 12: 4123-4134. (Pubitemid 44669741)
26. + T cells recognizing specific antigen deposited in glomeruli cause glomerulonephritis-like kidney injury. Clin. Immunol. 104: 161-173.
27. Ghosh, T. K., D. J. Mickelson, J. C. Solberg, K. E. Lipson, J. R. Inglefield, and S. S. Alkan. 2007. TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-α. Int. Immunopharmacol. 7: 1111-1121.
28. Theiner, G., S. Rossner, A. Dalpke, K. Bode, T. Berger, A. Gessner, and M. B. Lutz. 2008. TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells. Mol. Immunol. 45: 244-252. (Pubitemid 47331637)
29. Rothenfusser, S., E. Tuma, S. Endres, and G. Hartmann. 2002. Plasmacytoid dendritic cells: the key to CpG. Hum. Immunol. 63: 1111-1119. (Pubitemid 36025985)
30. Verthelyi, D., and R. A. Zeuner. 2003. Differential signaling by CpG DNA in DCs and B cells: not just TLR9. Trends Immunol. 24: 519-522. (Pubitemid 37205200)
31. Krieg, A. M. 2007. Development of TLR9 agonists for cancer therapy. J. Clin. Invest. 117: 1184-1194. (Pubitemid 46718403)
32. Flores, R. R., K. A. Diggs, L. M. Tait, and P. A. Morel. 2007. IFN-γ negatively regulates CpG-induced IL-10 in bone marrow-derived dendritic cells. J. Immunol. 178: 211-218.
33. Boonstra, A., R. Rajsbaum, M. Holman, R. Marques, C. Asselin-Paturel, J. P. Pereira, E. E. Bates, S. Akira, P. Vieira, Y. J. Liu, et al. 2006. Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J. Immunol. 177: 7551-7558. (Pubitemid 44846270)
34. Bohnenkamp, H. R., K. T. Papazisis, J. M. Burchell, and J. Taylor-Papadimitriou. 2007. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses. Cell. Immunol. 247: 72-84.
35. Asselin-Paturel, C., and G. Trinchieri. 2005. Production of type I interferons: plasmacytoid dendritic cells and beyond. J. Exp. Med. 202: 461-465. (Pubitemid 41186943)
36. Krieg, A. M. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20: 709-760.
37. Cross, A. R., and O. T. Jones. 1986. The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Specific labelling of a component polypeptide of the oxidase. Biochem. J. 237: 111-116.
38. Radeke, H. H., A. R. Cross, J. T. Hancock, O. T. Jones, M. Nakamura, V. Kaever, and K. Resch. 1991. Functional expression of NADPH oxidase components (α-and β-subunits of cytochrome b558 and 45-kDa flavoprotein) by intrinsic human glomerular mesangial cells. J. Biol. Chem. 266: 21025-21029.
39. Savina, A., C. Jancic, S. Hugues, P. Guermonprez, P. Vargas, I. C. Moura, A. M. Lennon-Dumenil, M. C. Seabra, G. Raposo, and S. Amigorena. 2006. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126: 205-218. (Pubitemid 44026552)
40. Thoren, F. B., A. Betten, A. I. Romero, and K. Hellstrand. 2007. Cutting edge: antioxidative properties of myeloid dendritic cells: protection of T cells and NK cells from oxygen radical-induced inactivation and apoptosis. J. Immunol. 179: 21-25.
41. --generating NADPH oxidase in dendritic cells. J. Cell Sci. 117: 2215-2226.
42. Hemmi, H., T. Kaisho, K. Takeda, and S. Akira. 2003. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J. Immunol. 170: 3059-3064. (Pubitemid 36304671)
43. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
44. Becher, B., B. G. Durell, and R. J. Noelle. 2002. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J. Clin. Invest. 110: 493-497. (Pubitemid 34919703)
45. Gutcher, I., and B. Becher. 2007. APC-derived cytokines and T cell polarization in autoimmune inflammation. J. Clin. Invest. 117: 1119-1127. (Pubitemid 46718396)
46. Prinz, M., F. Garbe, H. Schmidt, A. Mildner, I. Gutcher, K. Wolter, M. Piesche, R. Schroers, E. Weiss, C. J. Kirschning, et al. 2006. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Invest. 116: 456-464. (Pubitemid 43228363)
47. Romani, L., F. Fallarino, L. A. De, C. Montagnoli, C. D'Angelo, T. Zelante, C. Vacca, F. Bistoni, M. C. Fioretti, U. Grohmann, et al. 2008. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451: 211-215.
48. Gelderman, K. A., M. Hultqvist, A. Pizzolla, M. Zhao, K. S. Nandakumar, R. Mattsson, and R. Holmdahl. 2007. Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. J. Clin. Invest. 117: 3020-3028.
49. Baccala, R., K. Hoebe, D. H. Kono, B. Beutler, and A. N. Theofilopoulos. 2007. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat. Med. 13: 543-551. (Pubitemid 46828489)
50. Treschow, A. P., I. Teige, K. S. Nandakumar, R. Holmdahl, and S. Issazadeh-Navikas. 2005. Stromal cells and osteoclasts are responsible for exacerbated collagen-induced arthritis in interferon-β-deficient mice. Arthritis Rheum. 52: 3739-3748.
51. Yip, H. C., A. Y. Karulin, M. Tary-Lehmann, M. D. Hesse, H. Radeke, P. S. Heeger, R. P. Trezza, F. P. Heinzel, T. Forsthuber, and P. V. Lehmann. 1999. Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J. Immunol. 162: 3942-3949.
52. Chu, R. S., O. S. Targoni, A. M. Krieg, P. V. Lehmann, and C. V. Harding. 1997. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186: 1623-1631.